Topical chamomile oil as a novel therapeutic intervention for diabetic neuropathy: A randomized double-blind controlled clinical trial
EXPLORE · 2025
DOI: 10.1016/j.explore.2025.103189 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift EXPLORE, 2025. Verfasst von Mohammad Amiri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Traditional Medicine and History of Medicine, Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sc…. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Chamomile, Plant Oils. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Shiraz University of Medical Sciences.
Abstract (Originalsprache)
BACKGROUND: Diabetic neuropathy, a prevalent complication of diabetes mellitus, significantly impairs quality of life due to chronic pain and sensory deficits. Conventional pharmacotherapies, while effective, are often limited by systemic adverse effects. Chamomile (Matricaria chamomilla L.) oil, renowned for its anti-inflammatory, antioxidant, and analgesic properties, presents a promising topical alternative for mitigating neuropathic symptoms. OBJECTIVE: This study aimed to evaluate the efficacy of topical chamomile oil in improving neuropathy indices among patients with controlled diabetes, as measured by validated clinical tools. METHODS: A randomized, double-blind, placebo-controlled trial was conducted involving 72 participants with diabetic neuropathy. Participants were allocated to either the intervention group (chamomile oil) or the control group (placebo), with both groups continuing standard gabapentin therapy. Neuropathy outcomes were assessed using Neurothesiometer scores, the Michigan Neuropathy Screening Instrument (MNSI), and the DN4 questionnaire at baseline and post-intervention. ANCOVA was employed to analyze intergroup differences, adjusting for baseline covariates. RESULTS: The chamomile oil group exhibited statistically significant improvements in neuropathy indices compared to the placebo group (p < 0.05). Post-intervention, reductions in Neurothesiometer scores (mean difference: -1.14 ± 0.42), MNSI (-1.89 ± 0.31), and DN4 (-1.97 ± 0.28) were observed in the intervention group, with no comparable changes in controls. ANCOVA confirmed the robustness of these findings (F = 6.72, p = 0.012). CONCLUSION: Topical chamomile oil significantly alleviates neuropathic symptoms in diabetic patients, offering a safe and adjunctive therapeutic option. Its mechanism may involve modulation of oxidative stress and inflammatory pathways, warranting further investigation into long-term benefits and molecular targets. TRIAL REGISTRATION: This trial was registered at the Iranian Registry of Clinical Trials (IRCT), registration number IRCT20240611062090N1. The full protocol is available at www.irct.ir.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Traditional Medicine and History of Medicine, Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; Student research committee, School of Medicine,…
- Student research committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- School of Medicine, Iran university of medical sciences, Tehran, Iran.
- Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- MD-MPH Department, School of Medicine, Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: hosseinmolavi@ymail.com.
Förderung
- Shiraz University of Medical Sciences
Zitieren
APA
Amiri, M., Imani, M. H., Imani, A. H., Bazrafshan, H., Bazrafshan, M., Vardanjani, H. M., & Zohalinezhad, M. E. (2025). Topical chamomile oil as a novel therapeutic intervention for diabetic neuropathy: A randomized double-blind controlled clinical trial. EXPLORE. https://doi.org/10.1016/j.explore.2025.103189
Vancouver
Amiri M, Imani MH, Imani AH, Bazrafshan H, Bazrafshan M, Vardanjani HM, et al. Topical chamomile oil as a novel therapeutic intervention for diabetic neuropathy: A randomized double-blind controlled clinical trial. EXPLORE. 2025. doi:10.1016/j.explore.2025.103189
BibTeX
@article{Amiri2025,
author = {Amiri, Mohammad and Imani, Mohammad Hossein and Imani, Amir Hossein and Bazrafshan, Hanieh and Bazrafshan, Mehdi and Vardanjani, Hossein Molavi and Zohalinezhad, Mohammad Ebrahim},
title = {Topical chamomile oil as a novel therapeutic intervention for diabetic neuropathy: A randomized double-blind controlled clinical trial},
journal = {EXPLORE},
year = {2025},
doi = {10.1016/j.explore.2025.103189}
}
EUVIMED